RxDoctor Payments Data

Lowell Sensintaffar, MD

Family Medicine · Shiloh, ILNPI 1487649067

Payments from drug & device makers

$3,930in general payments, 2019–2025

Across 291 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$734
  • Lilly USA, LLC$514
  • AstraZeneca$349
  • Biohaven Pharmaceutical Holding Company Ltd.$141
  • Dexcom, Inc.$134
  • plus $755 from 16 others

What the payments were for

  • Food & beverage$3,930100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,930 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$97,377
Medicare patients
220
Services billed
1,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide110$129,399
TrulicityDulaglutide71$91,119
JardianceEmpagliflozin51$67,842
OzempicSemaglutide65$67,223
FarxigaDapagliflozin Propanediol42$50,970
XareltoRivaroxaban24$39,607
EliquisApixaban38$37,452
VraylarCariprazine Hcl11$15,319
Lantus SolostarInsulin Glargine,hum.Rec.Anlog68$8,873
Tresiba Flextouch U-100Insulin Degludec16$8,327
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$5,698
Azathioprine12$4,703
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$4,005
SymbicortBudesonide/Formoterol Fumarate17$3,784
Atorvastatin Calcium380$3,444

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$514$220,518181 claims
Boehringer IngelheimJardiance$85$67,84251 claims
Novo NordiskOzempic$734$67,22365 claims
AstraZenecaFarxiga, Symbicort$349$54,75459 claims
Johnson & JohnsonXarelto$22$39,60724 claims
PfizerEliquis$60$37,45238 claims
AbbVieVraylar$1,303$15,31911 claims
Sanofi-aventis U.S. LLCLantus$13$1,45212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Shiloh

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →